1. Medtech Insight
  2. >>Digital Technologies

US Senators Question FDA's Pre-Cert Program Authority, Concerned About Safety

Top Democratic lawmakers on the Senate HELP Committee have written to US FDA Commissioner Scott Gottlieb with questions about the agency's ongoing work to develop a pre-certification program that would allow medical software-makers to gain the agency's trust as a means to benefit from reduced or no pre-market review.

Capitol House

Three top Democratic Senators on the US Senate Health, Energy, Labor and Pensions Committee (HELP) want answers on US FDA's planned pre-certification program; they've sent Commissioner Gottlieb an extensive list of questions on the subject. The lawmakers are concerned the agency may be moving forward without proper statutory authority and are concerned the program may not provide the oversight needed to ensure medical software products meet the agency's level of safety and efficacy.

The agency has been developing the program, which remains in a pilot phase, for about the past two years. The...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

INBRAIN, Mayo Clinic To Test BCI With Standard Deep Brain Stimulation In Parkinson’s Patients

Barcelona-based INBRAIN Neuroelectronics is partnering with Mayo Clinic to test whether its graphene-based cortical brain computer interface can enhance standard DBS in Parkinson’s, aiming for more precise adaptive therapy and improved gait outcomes.

LSX Panel Takes On Present And Future Of Neurotech

 
• By Marion Webb

A Sept. 17 panel at LSX in Boston discussed how brain-computer interface devices (BCIs) work, potential applications for BCIs, partnership, the investment landscape, ethical considerations and the five to 10-year outlook for the neurotech sector.

60% Of Indian Hospitals See Workforce Upskilling As Top Barrier Despite Rising IT budgets: Survey

 
• By Shubham Singh

About 30% of providers flagged cybersecurity and data privacy as concerns while 40% pointed to patient engagement platforms as a challenge. By contrast, only 10% of respondents viewed AI and Gen AI applications or critical system upgrades as urgent priorities.

Mental Health The Focus Of Upcoming Digital Health Advisory Committee Meeting

 
• By Brian Bossetta

The US FDA will hold a public meeting of its Digital Health Advisory Committee in November to focus on generative AI-enabled medical devices to treat mental health.

More from Medtech Insight

Altaviva Approval A Big Win For Medtronic And Millions Struggling With Bladder Control

 
• By Brian Bossetta

The US FDA has approved Medtronic’s Altaviva, a subcutaneous device implanted near the ankle that offers a new treatment option for adults with urge urinary incontinence.

Execs On The Move: September 8–12, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

New Guidelines Support Early Intervention With Edwards TAVR Device Sapien

 
• By Natasha Barrow

The new ESC and EACTS guidelines allow aortic stenosis patients without symptoms to be considered for a transcatheter aortic valve replacement. The move opens the market for Edwards Lifesciences, the only medtech with a Europe and US-approved device for asymptomatic severe aortic stenosis.